Recent Updates on Predicting Conversion in Youth at Clinical High Risk for Psychosis

McGlashan TH, Walsh B, Woods SW. The psychosis-risk syndrome: handbook for diagnosis and follow-up. Oxford University Press. 2010.

Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, et al. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry. 2008;65(1):28–37.

Article  PubMed  PubMed Central  Google Scholar 

Addington J. The prodromal stage of psychotic illness: observation, detection or intervention? J Psychiatry Neurosci. 2003;28(2):93–7.

PubMed  PubMed Central  Google Scholar 

Fusar-Poli P, Bonoldi I, Yung AR, Borgwardt S, Kempton MJ, Valmaggia L, et al. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry. 2012;69(3):220–9.

Article  PubMed  Google Scholar 

Gee DG, Cannon TD. Prediction of conversion to psychosis: review and future directions. Braz J Psychiatry. 2011;33(Suppl 2):s129–42.

Article  PubMed  Google Scholar 

Addington J, Cadenhead KS, Cannon TD, Cornblatt B, McGlashan TH, Perkins DO, et al. North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophr Bull. 2007;33(3):665–72.

Article  PubMed Central  Google Scholar 

Salazar de Pablo G, Radua J, Pereira J, Bonoldi I, Arienti V, Besana F, et al. Probability of transition to psychosis in individuals at clinical high risk: an updated meta-analysis. JAMA Psychiat. 2021;78(9):970–8.

Article  Google Scholar 

Addington J, Farris M, Devoe D, Metzak P. Progression from being at-risk to psychosis: next steps. NPJ Schizophr. 2020;6(1):27.

Article  PubMed  PubMed Central  Google Scholar 

Addington J, Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, et al. Clinical and functional characteristics of youth at clinical high-risk for psychosis who do not transition to psychosis. Psychol Med. 2019;49(10):1670–7.

Article  PubMed  Google Scholar 

Allswede DM, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, et al. Characterizing covariant trajectories of individuals at clinical high risk for psychosis across symptomatic and functional domains. Am J Psychiatry. 2020;177(2):164–71.

Article  Google Scholar 

Addington J, Farris M, Stowkowy J, Santesteban-Echarri O, Metzak P, Kalathil MS. Predictors of transition to psychosis in individuals at clinical high risk. Curr Psychiatry Rep. 2019;21(6):39.

Article  PubMed  Google Scholar 

Bechdolf A, Thompson A, Nelson B, Cotton S, Simmons MB, Amminger GP, et al. Experience of trauma and conversion to psychosis in an ultra-high-risk (prodromal) group. Acta Psychiatr Scand. 2010;121(5):377–84.

Article  CAS  PubMed  Google Scholar 

Brucato G, Masucci MD, Arndt LY, Ben-David S, Colibazzi T, Corcoran CM, et al. Baseline demographics, clinical features and predictors of conversion among 200 individuals in a longitudinal prospective psychosis-risk cohort. Psychol Med. 2017;47(11):1923–35.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ciarleglio AJ, Brucato G, Masucci MD, Altschuler R, Colibazzi T, Corcoran CM, et al. A predictive model for conversion to psychosis in clinical high-risk patients. Psychol Med. 2019;49(7):1128–37.

Article  PubMed  Google Scholar 

Montemagni C, Bellino S, Bracale N, Bozzatello P, Rocca P. Models predicting psychosis in patients with high clinical risk: a systematic review. Front Psychiatry. 2020;11:223.

Article  PubMed Central  Google Scholar 

Bjornestad J, Tjora T, Langeveld JH, Stain HJ, Joa I, Johannessen JO, et al. Exploring specific predictors of psychosis onset over a 2-year period: a decision-tree model. Early Interv Psychiatry. 2022;16(4):363–70.

Article  Google Scholar 

Riecher-Rössler A, Studerus E. Prediction of conversion to psychosis in individuals with an at-risk mental state: a brief update on recent developments. Curr Opin Psychiatry. 2017;30(3):209–19.

Article  PubMed  Google Scholar 

•• Bolhuis K, Lång U, Gyllenberg D, Kääriälä A, Veijola J, Gissler M, et al. Hospital presentation for self-harm in youth as a risk marker for later psychotic and bipolar disorders: a cohort study of 59 476 Finns. Schizophr Bull. 2021;47(6):1685–94. Assessed individuals born in Finland in 1987 and found that of those who presented to the hospital for self-harm, 12.8% went on to receive a diagnosis of psychosis and 9.4% a diagnosis of bipolar disorder by 28 years of age. The investigators also found that younger age of first self-harm was associated with higher risk of conversion; 29.1% of those who presented with self-harm before the age of 18 developed a psychotic or bipolar disorder.

Article  PubMed  PubMed Central  Google Scholar 

Barbato M, Liu L, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan M, et al. Migrant status, clinical symptoms and functional outcome in youth at clinical high risk for psychosis: findings from the NAPLS-3 study. Soc Psychiatry Psychiatr Epidemiol. 2022.

Tronick LN, Mirzakhanian H, Addington J, Bearden CE, Cannon TD, Cornblatt BA, et al. Risk of violent behaviour in young people at clinical high risk for psychosis from the North American Prodrome Longitudinal Studies consortium. Early Interv Psychiatry. 2023.

Cannon TD, Yu C, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, et al. An Individualized risk calculator for research in prodromal psychosis. Am J Psychiatry. 2016;173(10):980–8.

Article  PubMed  PubMed Central  Google Scholar 

Lång U, Yates K, Leacy FP, Clarke MC, McNicholas F, Cannon M, et al. Systematic review and meta-analysis: psychosis risk in children and adolescents with an at-risk mental state. J Am Acad Child Adolesc Psychiatry. 2022;61(5):615–25.

Article  Google Scholar 

•• Collins MA, Ji JL, Chung Y, Lympus CA, Afriyie-Agyemang Y, Addington JM, et al. Accelerated cortical thinning precedes and predicts conversion to psychosis: The NAPLS3 longitudinal study of youth at clinical high-risk. Mol Psychiatry. 2022. CHR-C vs CHR-NC from the NAPLS3 sample had greater cortical thinning over time in the prefrontal, temporal, and parietal cortical regions.

Pantelis C, Velakoulis D, McGorry PD, Wood SJ, Suckling J, Phillips LJ, et al. Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet. 2003;361(9354):281–8.

Article  PubMed  Google Scholar 

Borgwardt SJ, McGuire PK, Aston J, Gschwandtner U, Pflüger MO, Stieglitz RD, et al. Reductions in frontal, temporal and parietal volume associated with the onset of psychosis. Schizophr Res. 2008;106(2–3):108–14.

Article  PubMed  Google Scholar 

Sun D, Phillips L, Velakoulis D, Yung A, McGorry PD, Wood SJ, et al. Progressive brain structural changes mapped as psychosis develops in “at risk” individuals. Schizophr Res. 2009;108(1–3):85–92.

Article  PubMed  PubMed Central  Google Scholar 

Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz RD, Drewe J, et al. Neuroimaging predictors of transition to psychosis–a systematic review and meta-analysis. Neurosci Biobehav Rev. 2010;34(8):1207–22.

Article  CAS  PubMed  Google Scholar 

Del Re EC, Stone WS, Bouix S, Seitz J, Zeng V, Guliano A, et al. Baseline cortical thickness reductions in clinical high risk for psychosis: brain regions associated with conversion to psychosis versus non-conversion as assessed at one-year follow-up in the Shanghai-At-Risk-for-Psychosis (SHARP) study. Schizophr Bull. 2021;47(2):562–74.

Article  PubMed  Google Scholar 

Kristensen TD, Glenthøj LB, Ambrosen K, Syeda W, Ragahava JM, Krakauer K, et al. Global fractional anisotropy predicts transition to psychosis after 12 months in individuals at ultra-high risk for psychosis. Acta Psychiatr Scand. 2021;144(5):448–63.

Article  PubMed  Google Scholar 

Nägele FL, Pasternak O, Bitzan LV, Mußmann M, Rauh J, Kubicki M, et al. Cellular and extracellular white matter alterations indicate conversion to psychosis among individuals at clinical high-risk for psychosis. World J Biol Psychiatry. 2021;22(3):214–27.

Article  PubMed  Google Scholar 

León-Ortiz P, Reyes-Madrigal F, Kochunov P, Gómez-Cruz G, Moncada-Habib T, Malacara M, et al. White matter alterations and the conversion to psychosis: a combined diffusion tensor imaging and glutamate. Schizophr Res. 2022;249:85–92.

Article  PubMed  Google Scholar 

Anticevic A, Haut K, Murray JD, Repovs G, Yang GJ, Diehl C, et al. Association of thalamic dysconnectivity and conversion to psychosis in youth and young adults at elevated clinical risk. JAMA Psychiat. 2015;72(9):882–91.

Article  Google Scholar 

Cao H, Chén OY, Chung Y, Forsyth JK, McEwen SC, Gee DG, et al. Cerebello-thalamo-cortical hyperconnectivity as a state-independent functional neural signature for psychosis prediction and characterization. Nat Commun. 2018;9(1):3836.

Article  PubMed  PubMed Central  Google Scholar 

Collin G, Seidman LJ, Keshavan MS, Stone WS, Qi Z, Zhang T, et al. Functional connectome organization predicts conversion to psychosis in clinical high-risk youth from the SHARP program. Mol Psychiatry. 2020;25(10):2431–40.

Article  PubMed  Google Scholar 

•• Chen OY, Cao H, Phan H, Nagels G, Reinen JM, Gou J, et al. Identifying neural signatures mediating behavioral symptoms and psychosis onset: High-dimensional whole brain functional mediation analysis. Neuroimage. 2021;226:117508. In an fMRI study of resting state, CHR-C vs CHR-NC from the NAPLS2 sample had increased activity in frontoparietal network, inferior temporal gyrus, cerebellum, negative mediators included DMN, thalamus, visual cortex, cerebellar lobe 8 assessed.

Article  PubMed  Google Scholar 

Cao H, Chung Y, McEwen SC, Bearden CE, Addington J, Goodyear B, et al. Progressive reconfiguration of resting-state brain networks as psychosis develops: preliminary results from the North American Prodrome Longitudinal Study (NAPLS) consortium. Schizophr Res. 2020;226:30–7.

Article  PubMed  Google Scholar 

de la Fuente-Sandoval C, Leon-Ortiz P, Azcarraga M, Favila R, Stephano S, Graff-Guerrero A. Striatal glutamate and the conversion to psychosis: a prospective 1H-MRS imaging study. Int J Neuropsychopharmacol. 2013;16(2):471–5.

Article  PubMed  Google Scholar 

de la Fuente-Sandoval C, Leon-Ortiz P, Favila R, Stephano S, Mamo D, Ramirez-Bermudez J, et al. Higher levels of glutamate in the associative-striatum of subjects with prodromal symptoms of schizophrenia and patients with first-episode psychosis. Neuropsychopharmacology. 2011;36(9):1781–91.

Article  PubMed  PubMed Central  Google Scholar 

Bustillo JR, Rowland LM, Mullins P, Jung R, Chen H, Qualls C, et al. 1H-MRS at 4 tesla in minimally treated early schizophrenia. Mol Psychiatry. 2010;15(6):629–36.

Article  CAS  PubMed  Google Scholar 

Kegeles LS, Mao X, Stanford AD, Girgis R, Ojeil N, Xu X, et al. Elevated prefrontal cortex gamma-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy. Arch Gen Psychiatry. 2012;69(5):449–59.

Article  CAS  PubMed  Google Scholar 

Stone JM, Day F, Tsagaraki H, Valli I, McLean MA, Lythgoe DJ, et al. Glutamate dysfunction in people with p

Comments (0)

No login
gif